Publications and Grants

  1. Alsalemi N, Sadowski C, Elftouh N, Kilpatrick K, Houle S, Leclerc S, Fernandez N, Lafrance JP. Designing and validating a clinical decision support algorithm for diabetic nephroprotection in older patients. BMJ Health & Care Informatics. 2024 Aug 28;31(1).
  2. Alsalemi N, Sadowski CA, Kilpatrick K, Elftouh N, Houle SK, Lafrance JP. Exploring key components and factors that influence the use of clinical decision-support tools for prescribing to older patients with kidney disease: the perspective of healthcare providers. BMC Health Services Research. 2024 Jan 23;24(1):126.
  3. Alsalemi N, Lafrance JP, Sadowski CA. Older Age, Kidney Concordant Diseases and the Dilemma of Adherence to Guidelines: A Narrative Review. Research in Social & Administrative Pharmacy, 2023 Apr 9. doi: https://doi.org/10.1016/j.sapharm.2023.04.115
  4. Alsalemi N, Sadowski C, Elftouh N, Louis M, Kilpatrick K, Houle S, Lafrance JP. The Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Continuous and Binary Kidney Outcomes in Subgroups of Patients with Diabetes: A Meta-Analysis of Randomized Clinical Trials. BMC Nephrology, 2022 Dec; 23(1):1-4.
  5. Alsalemi N, Sadowski C, Kilpatrick K, Elftouh N, Houle S, Leclerc S, Fernandez N, Lafrance JP. The Design and Validation of a Clinical Decision-Support Algorithm for the Prescribing of Renin-Angiotensin-Aldosterone System Inhibitors for Diabetic Nephroprotection in Older Patients: a Mixed Methods Study. Submitted – Under Review.
  6. Alsalemi N, Fernandez N, Aljabbour M, Sadowski C, Kilpatrick K, Houle S, Lafrance JP. Determining the Attitudes and Perceptions of Older Patients Attending Nephrology Clinics toward Clinical Decision-Support Tools. Submitted – Under Review.
  7. Alsalemi N, Sadowski C, Kilpatrick K, Elftouh N, Houle S, Lafrance JP. Exploring Key Components and Factors that Influence the Use of Clinical Decision- Support Tools for Prescribing to Older Patients with Renal Diagnosis: The Perspective of Healthcare Providers. Submitted – Under Review.
  8. Alsalemi N, Sadowski C, Elftouh N, Kilpatrick K, Houle S, Lafrance JP. (Encore Presentation) Exploring the Facilitators and Barriers Toward the Use of Clinical Decision- Support Tools by Healthcare Providers. American Geriatrics Society 2022 Annual Scientific Meeting. Journal of the American Geriatric Society, 2022 Apr; 70: IV-VIII: S234. https://doi.org/10.1111/jgs.17747
  9. Alsalemi N, Sadowski C, Elftouh N, Kilpatrick K, Houle S, Fernandez N, Lafrance JP. (Student Presentation) The Design of a Clinical Decision-Support Algorithm for the Prescribing of Renin-Angiotensin-Aldosterone System Inhibitors for Diabetic Nephroprotection in Older Patients. (2022), American Geriatrics Society 2022 Annual Scientific Meeting. Journal of the American Geriatric Society, 2022 Apr; 70: IV-VIII: S234. https://doi.org/10.1111/jgs.17747
  10. Alsalemi N, Sadowski C, Elftouh N, Kilpatrick K, Houle S, Lafrance JP. (Audio Poster) Exploring the Facilitators and Barriers Toward the Use of Clinical Decision- Support Tools by Healthcare Providers. (2022), Canadian Society of Hospital Pharmacists – Together Conference 2022. Canadian Journal of Hospital Pharmacy, 2022 Feb; 75 (2): 138.
  11. Harrak H, Réné E, Alsalemi N, Elftouh N, Lafrance JP. Osteoporotic Fracture Rates in Chronic Hemodialysis and Effect of Heparin Exposure: A Retrospective Cohort Study. BMC Nephrology, 2020 Dec;21(1):1-7.
  12. Alsalemi N, Elftouh N, Louis M, Sadowski C, Lafrance JP. The Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Binary and Continuous Renal Outcomes in Subgroups of Patients with Diabetes: An Extensive Meta-Analysis. Bioscientifica. In Endocrine Abstracts. 2021 May(73): doi:10.1530/endoabs.73.AEP206
  13. Alsalemi N, Elftouh N, Louis M, Sadowski C, Lafrance JP. The Efficacy and Safety of Renin-Angiotensin-Aldosterone System Inhibitors for the Prevention or Slowing of Diabetic Nephropathy in Patients with Diabetes: A Meta-Analysis Study. NHS – PROSPERO International Prospective Register of Systematic Reviews. 2020:  CRD42020149133
  14. Alsalimy N, Madi L, Awaisu A. Efficacy and Safety of Laxatives for Chronic Constipation in Long‐Term Care Settings: A Systematic Review. Journal of clinical pharmacy and therapeutics, 2018 Oct;43(5):595-605.
  15. Alsalimy N, Elkhalifa D, Al Shamaa A, Magdy M, Awaisu A. Characteristics and Quality of Adverse Drug Reaction Reporting: A Comparison of Pharmacists with Other Healthcare Providers at a Multi-Specialty Hospital in Qatar. Drugs and Therapy Perspectives, 2017;33, 283-289
  16. Madi L, Alsalimy N, Awaisu A. Efficacy and Safety of Laxatives for Chronic Constipation in Long-Term Care Settings: A Systematic Review Protocol. NHS – PROSPERO International Prospective Register of Systematic Reviews. 2016: CRD42016046117
  17. Awaisu A, Alsalimy N. Pharmacists’ Involvement in and Attitudes Toward Pharmacy Practice Research: A Systematic Review of the Literature. Research in Social and Administrative Pharmacy, 2015; 11(6): 25-48.
  18. Awaisu A, Kheir N, Alsalimy N, Babar Z. Book Chapter. Pharmacists’ Attitudes Toward Pharmacy Practice Research: A Review. In Pharmacy Practice Research Methods (ed. Z. Babar). 2015: Springer International Publishing.
  19. Alsalimy N, Awaisu A. Methoxy Polyethylene Glycol-epoetin Beta Versus Darbepoetin Alfa for Anemia in Non-dialysis Dependent CKD: A Systematic Review. International Journal of Clinical Pharmacy, 2014: 36(6): 1115-25.

Grants:

  1. Predictive Modelling for SGLT2 Inhibitor Treatment Success in Type 2 Diabetes Mellitus: Leveraging Qatar BioBank Data for Personalized Medicine
    1. Funding Agency: Qatar Research, Development and Innovation (QRDI) Council.
    2. Grant: Undergraduate Research Experience Program (UREP)– 31st  cycle
    3. Lead PI: Noor Alsalemi.
    4. Amount: $29,418
  2. Stakeholders’ Views on Factors Enabling or Hindering the Implementation of Clinical Pharmacy Services in the Private Healthcare Sector in Qatar
    1. Funding Agency: Qatar University.
    2. Grant: Student Grant
    3. Lead PI: Noor Alsalemi.
    4. Amount: 10,000 QR  
  3.  Inpatient Deprescribing Multidisciplinary Team Program for Older Patients with Polypharmacy in a Tertiary Care Hospital in Qatar (The IDMT Project)
    1. Funding Agency: Qatar University.
    2. Grant: QU Collaborative Grant Cycle 05
    3. Lead PI: Prof Dr. Ahmed Awaisu.
    4. Amount: 300,000 QR
    5. Role: Research design, proposal writing, team building, project management, Stakeholders management, development of educational materials, training of the Inpatient Deprescribing Multidisciplinary Team, research conduct, reporting, and manuscript writing.